Effects of oral 5-fluorouracil drugs on hepatic fat content in patients with colon cancer

Academic Radiology

Volumn 12, Issue 6, 2005, Pages 722-727

  Miyake, Kanae ^a   Hayakawa, Katsumi ^a   Nishino, Mizuki ^b   Morimoto, Taisuke ^a   Mukaihara, Sumio ^a  

^a KYOTO CITY HOSPITAL   (Japan)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Computed tomography; Hepatic steatosis; Oral 5 fluorouracil drug

Indexed keywords

DOXIFLURIDINE; FLUOROURACIL; UFT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; FAT CONTENT; FATTY LIVER; HUMAN; LIVER; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PRIORITY JOURNAL; SPLEEN; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COLONIC NEOPLASMS; FATTY LIVER; FEMALE; FLOXURIDINE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TEGAFUR; TOMOGRAPHY, X-RAY COMPUTED; URACIL;

EID: 20344398892     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2005.02.010     Document Type: Article

References (14)

1. P.D. Peppercorn, R.H. Reznek, P. Wilson Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer Br J Cancer 77 1998 2008 2011
2. C.G. Moertel, T.R. Fleming, J.S. Macdonald Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy J Clin Oncol 12 1993 2386 2390
3. P. Sorensen, A.L. Edal, E.L. Madsen Reversible hepatic steatosis in patients treated with interferon alfa-2a and 5-fluorouracil Cancer 75 1995 2592 2596
4. M. Nishino, K. Hayakawa, Y. Nakamura Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer AJR Am J Roentgenol 180 2003 129 134
5. G.B. Bydder, L. Kreel, R.W. Chapman Accuracy of computed tomography in diagnosis of fatty liver BMJ 281 1980 1042
6. C. Ricci, R. Longo, E. Gioulis Noninvasive in vivo quantitative assessment of fat content in human liver J Hepatol 27 1997 108 113
7. G.F. Gates, E.K. Dore Streamline flow in the human portal vein J Nucl Med 14 1973 79 83
8. ® containing tegafur and uracil Dig Dis Sci 40 1995 2434 2437
9. ® administration Hepatol Res 22 2000 161 165
10. 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma Magn Reson Imaging 12 1994 497 511
11. W.B. Parker, Y.C. Cheng Metabolism and mechanism of action of 5-fluorouracil Pharmacol Ther 48 1990 381 395
12. K. Ikeda, H. Kumada, Y. Arase Risk factors for side effects of long-term administration of 5-fluorourcil derivatives in patients with hepatocellular carcinoma associated with liver cirrhosis-relationship with serum concentration of anti-tumor agents and side effects [abstract in English] Jpn J Gastroenterol 85 1988 2411 2419
13. 19F-MRS Magn Reson Imaging 17 1999 283 290
14. R.B. Diasio Oral DPD-inhibitory fluoropyrimidine drugs Oncology (Huntingt) 14 2000 19 23